These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9130306)

  • 1. Cognitive function in schizophrenia--do neuroleptics make a difference?
    Mortimer AM
    Pharmacol Biochem Behav; 1997 Apr; 56(4):789-95. PubMed ID: 9130306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
    Meltzer HY; McGurk SR
    Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive function in schizophrenia: what impact do antipsychotics have?
    O'Grada C; Dinan T
    Hum Psychopharmacol; 2007 Aug; 22(6):397-406. PubMed ID: 17579928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.
    Keefe RS; Silva SG; Perkins DO; Lieberman JA
    Schizophr Bull; 1999; 25(2):201-22. PubMed ID: 10416727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptics and cognition].
    Brunnauer A; Geiger E; Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S106-9. PubMed ID: 14509053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.
    Velligan DI; Miller AL
    J Clin Psychiatry; 1999; 60 Suppl 23():25-8. PubMed ID: 10625197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond control of acute exacerbation: enhancing affective and cognitive outcomes.
    Meltzer HY
    CNS Spectr; 2003 Nov; 8(11 Suppl 2):16-8, 22. PubMed ID: 14978453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on cognition of the use of antipsychotics.
    Sharma T
    Curr Med Res Opin; 2002; 18 Suppl 3():s13-7. PubMed ID: 12418607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects and antipsychotic treatment.
    Kasper S; Resinger E
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():27-38. PubMed ID: 12504070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
    Gosselin O; Ribeyre JM; Kahn JP
    Encephale; 1997 Sep; 23 Spec No 4():2-6. PubMed ID: 9417400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
    Kahn JP
    Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia, psychotropic drugs and cognition].
    Fakra E; Kaladjian A; Adida M; Cermolacce M; Belzeaux R; Azorin JM
    Encephale; 2011 Dec; 37 Suppl 2():S137-42. PubMed ID: 22212844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the trail of a cognitive enhancer for the treatment of schizophrenia.
    Stip E; Chouinard S; Boulay LJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.
    Harvey PD; Keefe RS
    Am J Psychiatry; 2001 Feb; 158(2):176-84. PubMed ID: 11156796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive deficit in schizophrenia and its neurochemical basis.
    Breier A
    Br J Psychiatry Suppl; 1999; (37):16-8. PubMed ID: 10211135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in late life schizophrenia: a suitable case for treatment?
    Howard R
    Int J Geriatr Psychiatry; 1998 Jun; 13(6):400-4. PubMed ID: 9658275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.